Keywords: Celgene, PharmAria, Discovery collaboration, Cancer, Fibrotic diseases, Acquisition option

Celgene in deal with PharmAria, including an acquisition option

Article | 16 October 2012

Print This

Recently-formed drug discovery company PharmAria has entered into an agreement with US biotech firm Celgene (Nasdaq: CELG) to advance the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in